Phototherapy for Vitiligo.
Afamelanotide
JAK inhibitors
NBUVB
Phototherapy
Topical calcineurin inhibitors
Vitiligo
Journal
Dermatologic clinics
ISSN: 1558-0520
Titre abrégé: Dermatol Clin
Pays: United States
ID NLM: 8300886
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
2
6
2020
Statut:
ppublish
Résumé
Vitiligo is a common disorder with a severe impact on quality of life. The authors review recent advances in phototherapy for vitiligo focusing on narrowband ultraviolet B including mechanisms, treatment recommendations, and combination therapies. Phototherapy is the first-line treatment of choice for vitiligo with narrowband UVB preferred for widespread vitiligo and excimer used for localized lesions. However, unfamiliarity with prescribing phototherapy may be limiting clinicians from using it to its full potential. This article provides clinicians with the critical information needed to safely and effectively provide phototherapy for their patients with vitiligo.
Identifiants
pubmed: 31753192
pii: S0733-8635(19)30084-1
doi: 10.1016/j.det.2019.08.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-62Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.